EP3036320

BIOGEN MA INC.
Application Number
EP14761736A
Filing Date
Aug 19, 2014
Status
Patent Maintained As Amended
Mar 1, 2024
Grant Date
Apr 3, 2024
External Links
Slate, Register

Biblio Summary

The patent EP3036320B2 was granted on Apr 3, 2024 by Biogen Ma Inc. The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ABG INTELLECTUAL PROPERTY LAW, S.L.Jan 28, 2022ADMISSIBLE

The table below shows the patents of Biogen Ma Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2645106Methods And Products For Evaluating An Immune Response To A Therapeutic AgentOct 2, 20241
EP2956477Optimized Factor Viii GeneJan 24, 20241
EP3999643Methods Of Treating Or Preventing Spinal Muscular AtrophyNov 22, 20235